Lizenzübersicht

10 STOCKMEDIEN

DATUM	AUTOR	STOCKMEDIEN-ID	LIZENZ	MEDIENTYP	PREIS
04.10.23, 17:38	Zarina Lukash	#456498958	Standard	Standard-Bild	Verbraucht PACK-CREDITS
10.09.23, 16:33	Dimitrie	#612780404	Standard	Standard-Bild	Verbraucht PACK-CREDITS
30.07.23, 16:28	wangs	#371001551	Standard	Standard-Bild	Verbraucht PACK-CREDITS
30.07.23, 16:28	magicmine	#410866927	Standard	Standard-Bild	0,00 € KOSTENLOSER CREDIT
30.07.23, 16:26	amenic181	#146192029	Standard	Standard-Bild	Verbraucht PACK-CREDITS
30.07.23, 16:26	Dorthe Naumann	#555921088	Standard	Standard-Bild	Verbraucht PACK-CREDITS
30.07.23, 16:23	Анастасия Каргаполов	#471521618	Standard	Standard-Bild	Verbraucht PACK-CREDITS
27.07.23, 18:44	Christian Jung	#47425447	Standard	Standard-Bild	Verbraucht PACK-CREDITS
24.07.23, 14:53	nilanewsom	#64773861	Standard	Standard-Bild	Verbraucht PACK-CREDITS
24.07.23, 14:48	ckybe	#606130704	Standard	Standard-Bild	Verbraucht PACK-CREDITS

Literaturübersicht

Achufusi, Ted George O et al. “Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods.” Cureus vol. 12,6 e8860. 27 Jun. 2020.
Souza, Claudineia et al. “Diet and intestinal bacterial overgrowth: Is there evidence?.” World journal of clinical cases vol. 10,15 (2022): 4713-4716.
Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Am J Gastroenterol. 2020;115:190–201.
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. Maccaferri S, Vitali B, Klinder A, et al. J Antimicrob Chemother. 2010;65:2556–2565.
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Scarpellini E, Gabrielli M, Lauritano CE, et al. Aliment Pharmacol Ther. 2007;25:781–786.
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Gatta L, Scarpignato C. Aliment Pharmacol Ther. 2017;45:604–616.
Baumgartner, Maximilian et al. “Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.” Gastroenterology vol. 161,4 (2021): 1245-1256.e20.
Macfarlane, Sandra et al. “Mucosal biofilm communities in the human intestinal tract.” Advances in applied microbiology vol. 75 (2011): 111-43.
Polaquini, Sheila R B et al. “Effect of aqueous extract from Neem (Azadirachta indica A. Juss) on hydrophobicity, biofilm formation and adhesion in composite resin by Candida albicans.” Archives of oral biology vol. 51,6 (2006): 482-90.
Bauer, Benjamin W et al. “Oregano: A potential prophylactic treatment for the intestinal microbiota.” Heliyon vol. 5,10 e02625. 11 Oct. 2019,
Sasi, Minnu et al. “Garlic (Allium sativum L.) Bioactives and Its Role in Alleviating Oral Pathologies.” Antioxidants (Basel, Switzerland) vol. 10,11 1847. 21 Nov. 2021,
Ghosh, Siddhartha S et al. “Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects.” Tissue barriers vol. 6,1 (2018): e1425085.
Slingerland A. E., Schwabkey Z., Wiesnoski D. H., Jenq R. R. Clinical Evidence for the Microbiome in Inflammatory Diseases. Frontiers in Immunology. 2017;8(400)
Shin N.-R., Whon T. W., Bae J.-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends in Biotechnology. 2015;33(9):496–503.
Mirpuri J., Raetz M., Sturge C. R., et al. Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes. 2014;5(1):28–39
Winter S. E., Winter M. G., Xavier M. N., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013;339(6120):708–711.
Carvalho F. A., Koren O., Goodrich J. K., et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host & Microbe. 2012;12(2):139–152.
Rigottier-Gois L. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. The ISME Journal. 2013;7(7):1256–1261.
Byndloss M. X., Olsan E. E., Rivera-Chávez F., et al. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017;357(6351):570–575.
Chang CI, Cheng SY, Nurlatifah AO, Sung WW, Tu JH, Lee LL, Cheng HL. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions. Int J Med Sci. 2021 Feb 24;18(8):1848-1856. doi: 10.7150/ijms.55866. PMID: 33746602; PMCID: PMC7976585.
Cheng J, Ouwehand AC. Gastroesophageal Reflux Disease and Probiotics: A Systematic Review. Nutrients. 2020 Jan 2;12(1):132. doi: 10.3390/nu12010132. PMID: 31906573; PMCID: PMC7019778.
Esplugues JV, Barrachina MD, Beltrán B, Calatayud S, Whittle BJ, Moncada S. Inhibition of gastric acid secretion by stress: a protective reflex mediated by cerebral nitric oxide. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14839-44. doi: 10.1073/pnas.93.25.14839. PMID: 8962142; PMCID: PMC26223
Hu ML, Rayner CK, Wu KL, Chuah SK, Tai WC, Chou YP, Chiu YC, Chiu KW, Hu TH. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011 Jan 7;17(1):105-10. doi: 10.3748/wjg.v17.i1.105. PMID: 21218090; PMCID: PMC3016669.
Park JM, Jeong M, Kim EH, Han YM, Kwon SH, Hahm KB. Omega-3 Polyunsaturated Fatty Acids Intake to Regulate Helicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary Approach. Biomed Res Int. 2015;2015:712363. doi: 10.1155/2015/712363. Epub 2015 Aug 3. PMID: 26339635; PMCID: PMC4538587.
Nakov G.; Georgieva D.; Ivanova N.; Damyanova S.; Stamatovska V.; Necinova L.. Prebiotic effects of inulin and acacia gum. Food Environ. Saf. J.2016, 14
Calame W.; Weseler A. R.; Viebke C.; Flynn C.; Siemensma A. D. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. J. Geophys. Res. Oceans 2008, 100, 1269–1275. 10.1017/S0007114508981447
Rawi MH, Abdullah A, Ismail A, Sarbini SR. Manipulation of Gut Microbiota Using Acacia Gum Polysaccharide. ACS Omega. 2021 Jul 2;6(28):17782-17797. doi: 10.1021/acsomega.1c00302. PMID: 34308014; PMCID: PMC8296006.
Kamal E, Kaddam LA, Dahawi M, Osman M, Salih MA, Alagib A, Saeed A. Gum Arabic Fibers Decreased Inflammatory Markers and Disease Severity Score among Rheumatoid Arthritis Patients, Phase II Trial. Int J Rheumatol. 2018 Jul 5;2018:4197537. doi: 10.1155/2018/4197537. PMID: 30112005; PMCID: PMC6077585.
Rao R, Samak G. Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions. J Epithel Biol Pharmacol. 2012 Jan;5(Suppl 1-M7):47-54. doi: 10.2174/1875044301205010047. PMID: 25810794; PMCID: PMC4369670.
Ding LA, Li JS. Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia. World J Gastroenterol. 2003 Jun;9(6):1327-32. doi: 10.3748/wjg.v9.i6.1327. PMID: 12800250; PMCID: PMC4611810.

doi.org/10.1080/08910600310014377

doi: 10.1017/S0007114508981447

doi: 10.3390/nu12082196

doi: 10.1021/acsomega.1c00302